Effect of Virechana on serum biomarker (vasoactive intestinal polypeptide) to get clue on the mode of action of virechana in pakshaghata patients.

Effect of virechana on microbiota- gut- brain axis w.s.r vasoactive intestinal polypeptide in pakshaghata- An open labelled randomized controlled study. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056134

Enrollment

100

Registered

2023-08-04

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G988- Other disorders of nervous system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: stroke attack within one year of period of stroke and after 15 days of attack. Ischemic and hemorrhagic both type of stroke patients Conscious patient. Patients Yogya for Virechana.

Exclusion criteria

Exclusion criteria: Marked mental impairment. Patients have bed sores. Age above 65 yrs and below 20 yrs. Incontinence of bowel and bladder. Comatose and unconscious patients Uncontrolled DM, Hypertension, or any other systemic illness. Intracranial infections such as meningitis. Space occupying lesions of brain such as tumor Post traumatic paralysis patients. Congenital defects-diffuse sclerosis, cerebral agenesis etc. and other major illnesses. Patients Ayogya for Virechana.

Design outcomes

Primary

Measure	Time frame
Serum vasoactive intestinal polypeptide levelTimepoint: Day zero,A day After completion of treatment	—

Secondary

Measure	Time frame
Barthel index scoreTimepoint: Day zero.A day after the intervention	—

Countries

India

Contacts

Public ContactAdarsh P M

Institute of Teaching and Research in Ayurveda

anup_Thakar@yahoo.com9427776660

Outcome results